Skip to content
Back to search
📊 Intel view 📋 Audit JSON 🔄 Changelog
85
💰 Paid API

clinicalintelpulse.vercel.app

clinicalintelpulse.vercel.app · clinicalintelpulse.vercel.app

Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.

🛡
Own this agent?
Verify the domain clinicalintelpulse.vercel.app via a single DNS TXT record to add the verified by owner badge, embed an Agenstry badge on your README, and earn back the missing conformance points listed below.
Verify ownership
🔔 Watch this agent for changes. Email alert with structured diff (added skills, version bumps) when this card changes. Enterprise feature. Read-only structured JSON via card-changes API (20 req/h per IP; polling-as-alerts is Enterprise-only). Sign in to subscribe
Trust score
19/100
grade F · 9 criteria
Uptime
accumulating
1/5 probes
Revenue · 30d
$0.00
wallet active · no inflow
Usage · 7d
0
no recent activity
Card drift · 7d
changed
0 snapshots tracked
Owner
unverified
claim this listing →
F
Conformance score: 19/100
F-grade: card is reachable but fails most operational signals.
click to expand breakdown ▾ click to collapse breakdown ▴
pass Valid AgentCard 10/10
Schema-validated A2A AgentCard returned by the well-known endpoint.
info Live JSON-RPC 0/25
Live probe hasn't run yet.
fail Protocol version 0/10
No protocolVersion in card.
How to earn +10 points
Declare protocolVersion
Add `"protocolVersion": "1.0"` to the AgentCard root. Without it, callers can't negotiate v0.x vs v1.0 compatibility.
Docs →
info JWS signature 0/10
Card is unsigned (most published agents are).
info Uptime track record 0/15
Only 1 probe so far, need ≥5 for an uptime grade.
fail Skill declaration 0/10
No skills declared in card. Hard to route to.
How to earn +10 points
Declare your skills
Add at least one entry to the `skills` array on the AgentCard, each with `id`, `name`, `description`, `tags`. We canonicalise these into the global skill taxonomy on next probe.
Docs →
partial Verified Identity 5/10
Provider declared: clinicalintelpulse.vercel.app (https://clinicalintelpulse.vercel.app). Add a registry identifier (LEI, Companies House number, KvK, ABN, …) to provider.legalEntity for full verified-business credit.
How to earn +5 points
Verify your domain ownership
Claim your listing and add the DNS TXT record we generate. Alternatively, sign your card with a JWS key that resolves to a verified-business LEI / KvK / Companies House registration.
Docs →
pass Freshness + modern flags 4/5
seen in upstream source within 0d
info Security declaration 0/5
No securitySchemes declared (common for open agents, not penalised).
⚠ Card drift detected. This agent's agent-card.json changed within the last 7 days. We track these so downstream callers can react.

Activity (audit trail)

last 24h · 0 calls Public aggregate · no PII recorded

No calls observed in the last 7 days. Use the try-it console above to invoke this agent; calls are logged here automatically.

Uptime
100.0%
1 probes
Response
0ms
last probe
Skills
0
declared
Streaming
SSE-capable

Endpoints

Pricing x402 on Base USDC
From $0.1000 per call
Endpoint Price Currency
https://clinicalintelpulse.vercel.app/api/clinical/approval-outlook 0.25 USDC
https://clinicalintelpulse.vercel.app/api/clinical/deal-signal 0.35 USDC
https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape 0.35 USDC
https://clinicalintelpulse.vercel.app/api/clinical/failure-analysis 0.2 USDC
https://clinicalintelpulse.vercel.app/api/clinical/global-trials 0.15 USDC
https://clinicalintelpulse.vercel.app/api/clinical/mechanism-map 0.2 USDC
https://clinicalintelpulse.vercel.app/api/clinical/patient-finder 0.1 USDC
https://clinicalintelpulse.vercel.app/api/clinical/pipeline-scan 0.15 USDC
https://clinicalintelpulse.vercel.app/api/clinical/sponsor-intel 0.2 USDC
https://clinicalintelpulse.vercel.app/api/clinical/trial-brief 0.1 USDC
Try it ↗ Opens the operator's playground / docs in a new tab.
Settlement wallet: 0x50ab2018c06c6e4eaa9ba52057eb55ed284912fc · basescan ↗
Agent cardhttps://clinicalintelpulse.vercel.app
Providerhttps://clinicalintelpulse.vercel.app
Docshttps://clinicalintelpulse.vercel.app
Discovered via
agentic_market

Health · last 0 probes

When HTTP Live JSON-RPC Latency

Similar agents embedding-nearest

truthpulse-five.vercel.app
International FOI search for researcher and FOIA agents. Finds public records and files freedom-of-information requests in 15+ countries: UK
truthpulse-five.vercel.app · q 85%
chronicapulse.vercel.app
Military history research for genealogy and family-history agents. Returns service records, draft notices, casualty lists, and homecoming co
chronicapulse.vercel.app · q 85%
herbapulse.vercel.app
Cannabis intelligence for wellness and health agents. Returns the evidence base, drug interactions, and global legal status for cannabis and
herbapulse.vercel.app · q 85%
findpulse-omega.vercel.app
Scholarships I qualify for, find scholarships, financial aid finder, scholarships for my major. For student and funding agents: takes a stud
findpulse-omega.vercel.app · q 85%
govspendpulse.vercel.app
Federal contractor / vendor competitive intelligence and market-share analysis — who is winning federal contracts in your market. Returns to
govspendpulse.vercel.app · q 85%
patentpulse-self.vercel.app
International patent search / jurisdiction-specific patent lookup across EPO, WIPO PCT, CNIPA (China), KIPO (Korea), JPO (Japan), DPMA (Germ
patentpulse-self.vercel.app · q 85%

Embed your Agenstry badge

Paste any of these into your README, agent card, or marketing page. Each badge auto-updates and links back to this page.

Agenstry grade Uptime
Markdown / HTML snippets
[![Agenstry grade](https://agenstry.com/badge/clinicalintelpulse.vercel.app.svg)](https://agenstry.com/agents/clinicalintelpulse.vercel.app)
[![Verified Business](https://agenstry.com/badge/clinicalintelpulse.vercel.app/identity.svg)](https://agenstry.com/agents/clinicalintelpulse.vercel.app)
[![Uptime](https://agenstry.com/badge/clinicalintelpulse.vercel.app/uptime.svg)](https://agenstry.com/agents/clinicalintelpulse.vercel.app)
[![A2A version](https://agenstry.com/badge/clinicalintelpulse.vercel.app/protocol.svg)](https://agenstry.com/agents/clinicalintelpulse.vercel.app)

Audit-grade evidence bundle

JSON snapshot for vendor-review files. Add ?sign=true for a JWS-signed envelope verifiable against our JWKS. See the methodology.

audit.json audit.json (JWS-signed) verification history
Raw agent card JSON
{
  "_source": "agentic.market",
  "service": {
    "id": "clinicalintelpulse-vercel-app",
    "name": "clinicalintelpulse.vercel.app",
    "description": "Recruiting clinical trial finder for a disease or diagnosis \u2014 actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.",
    "domain": "clinicalintelpulse.vercel.app",
    "provider": "clinicalintelpulse.vercel.app",
    "providerUrl": "",
    "category": "",
    "networks": [
      "Base",
      "solana:5eykt4usfv8p8njdtrepy1vzqkqzkvdp"
    ],
    "enriched": false,
    "endpoints": [
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/approval-outlook",
        "description": "FDA/EMA drug approval probability + PDUFA calendar for a disease area \u2014 which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.",
        "pricing": {
          "amount": "0.25",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "agency",
            "type": "string",
            "description": "",
            "example": "FDA | EMA | both (default: both)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease area \u2014 e.g. \"Alzheimer Disease\" | \"Multiple Myeloma\" | \"NASH\" | \"Heart Failure\" | \"Obesity\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "horizon",
            "type": "string",
            "description": "",
            "example": "12m | 18m | 24m (default: 18m)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "fda-approval",
          "pdufa",
          "ema",
          "phase-3",
          "drug-approval"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/deal-signal",
        "description": "Biotech M&A + licensing deal signal for clinical-stage drugs \u2014 Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.",
        "pricing": {
          "amount": "0.35",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease area \u2014 e.g. \"Obesity\" | \"Cardiovascular\" | \"Oncology\" | \"Rare Neurological\" | \"Autoimmune\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "deal_type",
            "type": "string",
            "description": "",
            "example": "acquisition | licensing | both (default: both)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "stage",
            "type": "string",
            "description": "",
            "example": "phase2 | phase3 | both (default: both)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "biotech-ma",
          "licensing",
          "business-development",
          "deal-signal",
          "big-pharma"
        ],
        "quality": {
          "l30DaysTotalCalls": "4",
          "l30DaysUniquePayers": "2"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape",
        "description": "Competitive drug pipeline landscape for any disease \u2014 full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.",
        "pricing": {
          "amount": "0.35",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease area \u2014 e.g. \"Parkinson Disease\" | \"Breast Cancer\" | \"NASH\" | \"Heart Failure\" | \"Schizophrenia\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "depth",
            "type": "string",
            "description": "",
            "example": "standard | deep (default: standard)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "disease-landscape",
          "pipeline-intelligence",
          "drug-development",
          "competitive-intelligence",
          "oncology"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/failure-analysis",
        "description": "Clinical trial failure analysis for a disease area \u2014 why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.",
        "pricing": {
          "amount": "0.2",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease \u2014 e.g. \"Alzheimer Disease\" | \"Sepsis\" | \"ALS\" | \"Depression\" | \"NASH\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "trial-failure",
          "success-rates",
          "endpoint-selection",
          "patient-stratification",
          "drug-development"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/global-trials",
        "description": "Global clinical trial landscape for any disease \u2014 geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.",
        "pricing": {
          "amount": "0.15",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease \u2014 e.g. \"Malaria\" | \"Tuberculosis\" | \"Dengue\" | \"Sickle Cell Disease\" | \"Chagas Disease\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "region",
            "type": "string",
            "description": "",
            "example": "global | africa | asia | europe | latin-america | middle-east | north-america (default: global)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "global-trials",
          "who-ictrp",
          "china-trials",
          "india-trials",
          "global-health"
        ],
        "quality": {
          "l30DaysTotalCalls": "6",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/mechanism-map",
        "description": "Drug mechanism-of-action + molecular target landscape for any disease \u2014 targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.",
        "pricing": {
          "amount": "0.2",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease \u2014 e.g. \"Treatment-Resistant Depression\" | \"ALS\" | \"Lupus\" | \"Multiple Sclerosis\" | \"Prostate Cancer\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "mechanism",
            "type": "string",
            "description": "",
            "example": "Optional \u2014 specific mechanism to focus on, e.g. \"BTK inhibitor\" | \"IL-17\" | \"CAR-T\"",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "mechanism-of-action",
          "drug-target",
          "moa",
          "drug-discovery",
          "first-in-class"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/patient-finder",
        "description": "Recruiting clinical trial finder for a disease or diagnosis \u2014 actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.",
        "pricing": {
          "amount": "0.1",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease or diagnosis \u2014 e.g. \"Glioblastoma\" | \"Sickle Cell Disease\" | \"Cystic Fibrosis\" | \"Huntington Disease\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "country",
            "type": "string",
            "description": "",
            "example": "Optional country filter \u2014 e.g. \"United States\" | \"United Kingdom\" | \"Germany\" | \"Australia\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "phase",
            "type": "string",
            "description": "",
            "example": "phase2 | phase3 | any (default: any)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "patient-recruitment",
          "recruiting-trials",
          "clinical-trial-finder",
          "rare-disease",
          "patient-advocacy"
        ],
        "quality": {
          "l30DaysTotalCalls": "6",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/pipeline-scan",
        "description": "Clinical trial pipeline scan for any disease \u2014 all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.",
        "pricing": {
          "amount": "0.15",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "condition",
            "type": "string",
            "description": "",
            "example": "Disease or condition \u2014 e.g. \"Non-Small Cell Lung Cancer\" | \"Alzheimer Disease\" | \"Type 2 Diabetes\" | \"Crohn Disease\" | \"Multiple Myeloma\"",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "phase",
            "type": "string",
            "description": "",
            "example": "phase2 | phase3 | both (default: both)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "status",
            "type": "string",
            "description": "",
            "example": "active | all (default: active \u2014 recruiting + active not recruiting)",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "clinical-trials",
          "phase-3",
          "pipeline",
          "drug-development",
          "oncology"
        ],
        "quality": {
          "l30DaysTotalCalls": "9",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/sponsor-intel",
        "description": "Pharma/biotech company pipeline intelligence \u2014 full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.",
        "pricing": {
          "amount": "0.2",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "focus",
            "type": "string",
            "description": "",
            "example": "pipeline | approvals | deals | all (default: all)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "sponsor",
            "type": "string",
            "description": "",
            "example": "Company name \u2014 e.g. \"Moderna\" | \"BioNTech\" | \"Alnylam\" | \"Vertex Pharmaceuticals\" | \"Regeneron\"",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "pharma-pipeline",
          "sponsor-intel",
          "competitive-intelligence",
          "biotech",
          "big-pharma"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      },
      {
        "url": "https://clinicalintelpulse.vercel.app/api/clinical/trial-brief",
        "description": "Clinical trial deep dive by NCT ID \u2014 full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.",
        "pricing": {
          "amount": "0.1",
          "currency": "USDC",
          "network": "eip155:8453",
          "scheme": "exact",
          "maxAmount": "",
          "minAmount": ""
        },
        "method": "GET",
        "providerName": "",
        "parameters": [
          {
            "group": "query",
            "name": "lang",
            "type": "string",
            "description": "",
            "example": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "enumValues": [],
            "default": null,
            "required": false
          },
          {
            "group": "query",
            "name": "nct_id",
            "type": "string",
            "description": "",
            "example": "NCT identifier \u2014 e.g. \"NCT04368728\" | \"NCT05116748\" | \"NCT04815993\"",
            "enumValues": [],
            "default": null,
            "required": false
          }
        ],
        "serviceName": "ClinicalIntelPulse",
        "tags": [
          "clinical-trial",
          "nct-id",
          "trial-design",
          "endpoints",
          "enrollment"
        ],
        "quality": {
          "l30DaysTotalCalls": "5",
          "l30DaysUniquePayers": "3"
        }
      }
    ],
    "integrationType": "",
    "isNew": false,
    "priceSummary": {
      "minAmount": "0.1",
      "maxAmount": "0.35",
      "avgCostPerTransaction": "0.205",
      "avgCostBasis": "exact",
      "currency": "USDC"
    },
    "serviceName": "ClinicalIntelPulse",
    "tags": [
      "fda-approval",
      "pdufa",
      "ema",
      "phase-3",
      "drug-approval",
      "biotech-ma",
      "licensing",
      "business-development",
      "deal-signal",
      "big-pharma",
      "disease-landscape",
      "pipeline-intelligence",
      "drug-development",
      "competitive-intelligence",
      "oncology",
      "trial-failure",
      "success-rates",
      "endpoint-selection",
      "patient-stratification",
      "global-trials",
      "who-ictrp",
      "china-trials",
      "india-trials",
      "global-health",
      "mechanism-of-action",
      "drug-target",
      "moa",
      "drug-discovery",
      "first-in-class",
      "patient-recruitment",
      "recruiting-trials",
      "clinical-trial-finder",
      "rare-disease",
      "patient-advocacy",
      "clinical-trials",
      "pipeline",
      "pharma-pipeline",
      "sponsor-intel",
      "biotech",
      "clinical-trial",
      "nct-id",
      "trial-design",
      "endpoints",
      "enrollment"
    ],
    "iconUrl": ""
  }
}